Sign Up
Login
Try for Free
Login
A mental health risk screening note documents a brief, standardized screen for suicide, violence, abuse, substance use, and psychosis risk: the instrument used, the result for each domain, a positive or negative determination, and the follow-up action. Therapists and intake staff complete it at intake or when concerns arise, often inside the intake or progress note. Most run 50 to 150 words.
Therapists, intake staff, and trained front-line staff, with licensed clinician review of positive screens
Treating clinician, care team, supervisors, accreditation surveyors, auditors
50 to 150 words · 2 to 5 minutes by hand (clinical team estimate)
Short structured screen or checklist (compare: suicide risk assessment, intake note)
At intake, at re-screening intervals the organization sets, and when clinical status changes
Accreditation standard in accredited settings (Joint Commission, NSQHS); convention in private practice, usually embedded in the intake or progress note
A mental health risk screening note records a brief, standardized screen for safety concerns: suicide risk, self-harm, violence toward others, abuse or safety at home, substance use, and indicators of psychosis. It captures the instrument used, the result for each domain, an explicit positive or negative determination, and the follow-up action taken. The instruments that standardized this note type are the Columbia Suicide Severity Rating Scale (Posner and colleagues, 2011), whose short Screener version exists for routine triage, item 9 of the PHQ-9 (Kroenke, Spitzer, and Williams, 2001), and the NIMH's four-question ASQ (Horowitz and colleagues, 2012), which takes about 20 seconds to administer. You will also hear the record called a suicide risk screen, an SI/HI screen, a safety screen, or, loosely, a risk assessment. It rarely stands alone: most practices embed it in the intake note or a progress note, or keep it as a one-page screening flowsheet.
The distinction that carries this page: a screen is not an assessment. A screen is a triage step that answers one question, whether further evaluation is needed, and its job is routing. A negative screen is documented honestly and the visit moves on; a positive screen triggers a full suicide risk assessment, and the note shows that handoff. No federal statute, and essentially no state statute, requires an outpatient therapist to administer a formal screen at every session. The force behind screening is accreditation: Joint Commission standard NPSG.15.01.01, an accreditation standard rather than a law, has required accredited hospitals and behavioral health organizations since July 2019 to screen individuals aged 12 and older who present with a behavioral health condition as their primary reason for care, using a validated tool. Even there, the Joint Commission's R3 Report states the goal "does not require universal screening for suicidal ideation" of medical patients. In private practice, screening at intake is a professional convention backed by the malpractice standard of care, not a statutory mandate.
Outpatient therapists and group practices screen at intake and when something shifts: new stressors, a status change, or ideation surfacing mid-treatment. Accredited settings screen on a schedule: hospital intake, emergency departments, community mental health centers, and integrated care clinics run validated screens under Joint Commission, Accreditation Canada, or NSQHS requirements and re-screen at intervals the organization sets. The C-SSRS Screener and the ASQ were designed so intake coordinators, nurses, and other front-line staff can administer them after brief training, with a licensed clinician taking over the moment a result is positive. Reach for this note when you need a fast, documented answer to whether further evaluation is needed. When the concern is specific from the start, skip the general screen and go straight to the deeper document: a full suicide risk assessment for suicide concerns, the violence risk assessment when the risk runs toward others, or the self-harm assessment for non-suicidal self-injury.
Header and context. Client identifier, date and time, setting (intake, routine visit, or re-screen), and who administered the screen. Time matters more here than in most notes: when a positive screen escalates, the record has to show how quickly the next step happened. Pitfall: no time recorded; a same-morning escalation you cannot place on a clock reads like a delay to a reviewer.
Instrument and version. Name the tool exactly: C-SSRS Screener, ASQ, PHQ-9 with item 9 reviewed, or your clinic checklist with its version date, and file or reference the completed instrument. Accreditors expect a validated tool, and a validated tool means a named one. Pitfall: a narrative line like "denies SI/HI" with no instrument behind it; to a surveyor or a plaintiff's expert, that line is not evidence a screen occurred.
Domains and results. One line per domain screened: suicide risk, self-harm, violence toward others, abuse or safety at home, substance use, psychosis indicators. Record a result for every domain, including the negatives. Pitfall: documenting only the domain that came back positive; silent negatives leave no proof the other questions were asked.
Determination. One explicit line: negative screen, or positive screen with the domain named. This is the triage output everything downstream depends on, and the place to note when clinical judgment overrides a negative instrument result, which NIMH's ASQ guidance expressly allows. Pitfall: raw responses filed with no stated determination, leaving the next reader to score the screen themselves.
Follow-up action and routing. What happened because of the determination: no further evaluation indicated, a full suicide risk assessment completed or scheduled with clinician and date, a safety plan, a referral, or an escalation with a name and a time. Every positive screen needs a documented next step. Pitfall: the screen-without-follow-up gap; in published EHR reviews, between one in five and one in three positive screens had no documented provider follow-up.
Sign-off. Name, credentials, signature, and date and time signed. If a non-clinician administered the screen, add the licensed clinician who reviewed the result. Pitfall: missing or late authentication; missing provider signatures were among the most common failures in the OIG's national psychotherapy audit.
GENERAL RISK SCREENING NOTE
Client: [initials] Date: __________ Time: __________
Setting: [ ] intake [ ] routine visit [ ] re-screen
Administered by (name, role): _________________________________________
INSTRUMENT (name and version; file or reference the completed tool)
_______________________________________________________________________
DOMAINS SCREENED (one result per domain)
Negative Positive Declined
Suicide risk [ ] [ ] [ ]
Self-harm [ ] [ ] [ ]
Violence toward others [ ] [ ] [ ]
Abuse or safety at home [ ] [ ] [ ]
Substance use [ ] [ ] [ ]
Psychosis indicators [ ] [ ] [ ]
DETERMINATION
[ ] Negative screen [ ] Positive screen, domain(s): _________________
Clinical judgment note (may override a negative result): ______________
FOLLOW-UP ACTION (required for every positive screen)
[ ] No further evaluation indicated
[ ] Full assessment (type, clinician, date/time): _____________________
[ ] Safety plan [ ] Referral: _______________________________________
[ ] Escalated to (name, time): ________________________________________
Administered by (signature/credentials/date/time): ____________________
Reviewed by licensed clinician (if applicable): _______________________Free to use and share, no signup. The PDF includes a one-page cheat sheet with section-by-section pitfalls and a pre-sign checklist; the DOCX is the blank template, ready to adapt.
Scenario: adult intake at an outpatient therapy practice. The screen is negative on five domains and positive on one, and the positive result routes to a full suicide risk assessment the same morning. All details are fictional.
Risk Screening Note. Client: R.L., 41 · Date: 08/05/2026 · Time: 10:20 · Setting: Intake, outpatient behavioral health · Administered by: M. Sandoval, Intake Coordinator
Instrument: C-SSRS Screener administered verbally per clinic intake protocol; completed screener filed in the chart with this note. Clinic intake safety checklist (v2.3, March 2026) used for the remaining domains.
Domains and results:
Suicide risk (C-SSRS Screener): POSITIVE
Self-harm: negative
Violence toward others: negative
Abuse or safety at home: negative
Substance use: negative
Psychosis indicators: negative
Determination: Positive screen, suicide risk domain; all other domains negative. Clinical judgment consistent with the instrument result.
Follow-up action: Escalated at 10:26 to C. Reyes, PhD, licensed psychologist on site. Client remained with intake staff until handoff at 10:31. Full suicide risk assessment completed by Dr. Reyes beginning 10:40 and documented separately in the assessment note of 08/05/2026. Intake resumed after the assessment per Dr. Reyes' disposition.
Administered by: M. Sandoval, Intake Coordinator, signed 08/05/2026, 10:28
Reviewed by: C. Reyes, PhD, 08/05/2026, 11:05
This sample is fictional and for educational purposes. It does not describe a real patient.
Writing these after every session? BastionGPT drafts complete notes from bullets, dictation, or a transcript.
Generate a note from bulletsLocate yourself on the regulatory map first, because the rule that reaches a hospital intake desk does not reach a solo practice. In accredited organizations, screening is enforceable: Joint Commission NPSG.15.01.01 has required validated-tool screening since July 2019, a positive screen must trigger an evidence-based assessment, and the overall risk level and mitigation plan must be documented. That is an accreditation standard; it functions like law through deemed status, but it is not a statute. From January 1, 2026, hospitals and critical access hospitals carry the requirement as National Performance Goal 8 under the Joint Commission's restructured goals, while behavioral health organizations remain on NPSG 15. Canada reaches the same place through an Accreditation Canada Required Organizational Practice dating to 2008, now formalized as CAN/HSO 5064:2023, and Australia through NSQHS Comprehensive Care Standard 5 (Actions 5.31 and 5.32), with the Psychology Board's enforceable Code of Conduct adding prescriptive record-keeping from December 1, 2025. For unaccredited private practice, no statute in any of the three countries requires a per-visit screen. What some US states legislate instead is training: Washington's RCW 43.70.442 requires six hours of suicide-assessment training every six years for listed professions, a competency law, not a documentation law. The outpatient convention that holds up under review: screen at intake and when clinical status changes, and document negative results as carefully as positive ones.
The billing layer is narrower than vendor guides suggest, and it is payer policy, not law. Many commercial payers accept 96127 for a brief standardized instrument, with per-day unit caps and bundling edits that usually block separate payment on the same day as psychotherapy or a 90791 evaluation. Medicare's G0444 covers annual depression screening only in primary care settings and cannot be billed by psychologists or clinical social workers, one of the most repeated billing mistakes in behavioral health. In Australia, no separate MBS item attaches to a screen performed inside a Better Access session. None of this changes the documentation duty. The screening note is part of the standard clinical record, it follows the retention rules of whatever record it lives in, and the format is a convention while the content is the requirement: instrument, result per domain, determination, follow-up, signature, and time. Keep the chain navigable: a reviewer should be able to walk from a positive screen to the assessment it triggered and on to any resulting safety plan without guesswork.
If you or a client needs immediate support: call or text 988 (US), 9-8-8 (Canada), or Lifeline 13 11 14 (Australia).
Two bodies of evidence frame this list. On the payment side, the HHS Office of Inspector General's national audit of Medicare psychotherapy services estimated $580 million in improper payments in a single year, with missing provider signatures among the most common failures. On the clinical side, published EHR reviews quantify the screening-specific failure: a 2018 study of 2,134 screened adolescents found documented follow-up for only 83% of positive screens, and a 2024 quality-improvement review found that just 67.7% of positive suicidal-ideation screens had documentation acknowledging the result. The BastionGPT Clinical Advisory Board sees the same errors most often in risk screening note reviews:
BastionGPT is specifically trained, tuned, and clinically tested on general risk screening notes.
See how clinicians use it day to day on the AI therapy notes page.
Many BastionGPT users report saving more than 90 minutes per day on documentation.
HIPAA-compliant with a signed BAA on every plan. Your data is never used to train models. BastionGPT drafts, you review and sign.
No. No US federal statute, no CMS manual provision, and no accreditation element requires an outpatient private-practice therapist to run a formal screen at every session. Accredited organizations screen patients presenting with behavioral health conditions and set their own re-screening intervals, and the C-SSRS has a shorter Since Last Visit version built for exactly that. The defensible outpatient pattern: screen at intake, then again when status changes, new stressors appear, or ideation surfaces in session.
A screen is a brief triage step with a standardized tool, and it answers one question: is further evaluation needed. An assessment is the comprehensive clinical formulation a positive screen triggers, covering risk and protective factors, history, and a documented overall risk level with a plan. The two carry different audit expectations, so label each note honestly. The suicide risk assessment template covers the deeper document.
Most run 50 to 150 words, because the validated instrument does the heavy lifting: the ASQ takes about 20 seconds to administer, the PHQ-9 one to three minutes, and the C-SSRS Screener a minute or two when symptoms are absent. The note does not need to stand alone. Many practices embed it in the intake note or a progress note, or keep a screening flowsheet; what matters is that the elements are findable: instrument, results, determination, follow-up, signature, and time.
Name the instrument and version, record the responses or triage result for every domain, state the negative determination in its own line, and sign with credentials, date, and time. NIMH's ASQ guidance is explicit that "clinical judgment can always override a negative screen," so note when your judgment confirmed, or overrode, the instrument result.
Clinically, any endorsement deserves a documented next step. In a study of more than 200,000 questionnaires, patients answering "nearly every day" on item 9 had a 6.37 times higher hazard of a subsequent suicide attempt than those answering "not at all," and their one-year attempt risk was roughly ten times higher in absolute terms. A positive item 9 does not automatically mean hospitalization. It means a documented response: a brief safety assessment, a full assessment, or a clearly reasoned clinical decision, signed and timed.
No. The requirement is a validated tool, not a named one. The Joint Commission's own FAQ confirms that no specific instrument is required and that different departments may use different tools; the C-SSRS, the ASQ, and PHQ-9 item 9 are the common choices. Track the 2026 change too: hospitals and critical access hospitals now carry suicide-risk reduction as National Performance Goal 8, part of a restructuring that cut the accreditation manual from 1,551 requirements to 774, while behavioral health organizations remain on NPSG 15.
The C-SSRS and ASQ were designed for administration by non-mental-health staff after brief training, which is why intake coordinators and nurses run them in many settings; a licensed clinician takes over the moment a screen is positive. Billing is a separate, narrower question. Many commercial payers accept 96127 per standardized instrument, with unit caps and edits that usually block separate payment alongside same-day psychotherapy or 90791. Medicare's G0444 covers annual depression screening only in primary care and cannot be billed by psychologists or clinical social workers, and in Australia no separate MBS item attaches to a screen done inside a Better Access session. Verify your own payer's policy before building billing into the workflow.
The pattern matches the US: accreditation and professional standards, not statutes. Accreditation Canada has treated suicide risk assessment and monitoring as a Required Organizational Practice since 2008, now formalized in CAN/HSO 5064:2023, and provincial colleges govern records, with retention commonly around 10 years. Australia's NSQHS Comprehensive Care Standard 5 (Actions 5.31 and 5.32) requires accredited health services to screen and respond, and the Psychology Board's Code of Conduct, enforceable since December 1, 2025, added prescriptive record-keeping; the retention convention is 7 years from last contact, or until a minor turns 25. Private practitioners in both countries screen by professional convention and standard of care.
Yes. Dictate the intake recap, paste the relevant part of a transcript, or give it a few bullets, and BastionGPT drafts the structured note: instrument, a result for every domain, the determination, and the follow-up line, ready for your review. It can also check a finished note for silent domains or a missing next step before you sign. BastionGPT is HIPAA-compliant with a signed BAA on every plan, and your data is never used to train models.
Educational content, not legal or billing advice. Sample notes are fictional. Follow your organization's policies and your board, payer, and jurisdiction requirements.